Maze Therapeutics, Inc.
MAZE
$14.26
$0.957.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -124.22% | -0.90% | -11.30% | -0.02% | 666.52% |
| Total Depreciation and Amortization | -24.00% | -28.00% | -27.77% | -21.51% | -19.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.25% | -48.96% | -25.19% | 113.35% | -6.60% |
| Change in Net Operating Assets | -142.73% | -672.29% | 145.86% | -643.30% | 196.56% |
| Cash from Operations | -120.72% | -25.94% | -8.76% | -16.19% | 727.75% |
| Capital Expenditure | -145.63% | -7.17% | -1,679.41% | -3,533.33% | 21.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -145.63% | -7.17% | -1,679.41% | -3,533.33% | 21.95% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 674.68% | 34,935.07% | 425.00% | 2,725.00% | -16.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | 297.40% | 418.20% | 334.04% | -26,975.00% | 62.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.57% | 11,178.96% | 1,151.57% | -27.54% | 724.74% |